Smiths Detection

Smiths Detection Launches BIO-ACT, a Complete Solution for Emergency Response BWA Threat Assessment

Published in Medical Letter on the CDC and FDA, March 21st, 2010

Smiths Detection today launches BIO-ACT, a complete emergency response assessment solution for rapidly identifying Biological Warfare Agents (BWAs) in the field. BIO-ACT comprises four complementary technologies, giving emergency responders a complete toolkit to obtain the highest level of accuracy when assessing unknown powder scares for Anthrax, Ricin, Plague, Pan Orthopox and other BWAs.

BIO-ACT, which stands for biological advanced confirmatory technologies, consists of Prime Alert™, a microbe and toxin screener, BioCheck®, a protein and pH test kit, HazMatID Ranger™, a hand-held chemical identifier and Bio-Seeq PLUS™, a next-generation...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2010-03-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry

Search our medical news database